N-Boc-N-deshydroxyethyl Dasatinib

Synchemia is a leading supplier in pharmaceutical Dasatinib Impurities . Dasatinib (marketed as Sprycel) is a kinase inhibitor primarily used to treat Philadelphia chromosome-positive Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) in adults and children. It treats newly diagnosed cases and patients resistant or intolerant to prior therapy, including imatinib.

N-Boc-N-deshydroxyethyl Dasatinib CAS NO: 1159977-13-5 chemically represented as Tert-butyl 4-(6-((5-((2-chloro-6-methylphenyl)carbamoyl)thiazol-2-yl)amino)-2-methylpyrimidin-4-yl)piperazine-1-carboxylate . It is also known as N-Boc-N-deshydroxyethyl Dasatinib . N-Boc-N-deshydroxyethyl Dasatinib is supplied with comprehensive characterization data, in full compliance with applicable regulatory guidelines. Synchemia is the leading supplier and exporter of N-Boc-N-deshydroxyethyl Dasatinib . All Synchemia products are strictly intended for analytical testing purposes only and not for human use.